365 related articles for article (PubMed ID: 34238227)
1. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.
Crothers JW; Chu ND; Nguyen LTT; Phillips M; Collins C; Fortner K; Del Rio-Guerra R; Lavoie B; Callas P; Velez M; Cohn A; Elliott RJ; Wong WF; Vo E; Wilcox R; Smith M; Kassam Z; Budd R; Alm EJ; Mawe GM; Moses PL
BMC Gastroenterol; 2021 Jul; 21(1):281. PubMed ID: 34238227
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
[TBL] [Abstract][Full Text] [Related]
3. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A
Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638
[TBL] [Abstract][Full Text] [Related]
4. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
5. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
7. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
[TBL] [Abstract][Full Text] [Related]
8. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.
Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C
Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fecal microbiota transplantation
Tkach S; Dorofeyev A; Kuzenko I; Falalyeyeva T; Tsyryuk O; Kovalchuk O; Kobyliak N; Abenavoli L; Boccuto L
Front Med (Lausanne); 2022; 9():1049849. PubMed ID: 36714101
[TBL] [Abstract][Full Text] [Related]
10. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
11. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation.
Chen Q; Fan Y; Zhang B; Yan C; Zhang Q; Ke Y; Chen Z; Wang L; Shi H; Hu Y; Huang Q; Su J; Xie C; Zhang X; Zhou L; Ren J; Xu H
Microbiol Spectr; 2023 Jun; 11(3):e0415222. PubMed ID: 37093057
[TBL] [Abstract][Full Text] [Related]
12. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.
Huang C; Huang Z; Ding L; Fu Y; Fan J; Mei Q; Lou L; Wang J; Yin N; Lu Y; Guo S; Zeng Y
J Transl Med; 2022 Aug; 20(1):354. PubMed ID: 35962454
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial.
Lahtinen P; Jalanka J; Mattila E; Tillonen J; Bergman P; Satokari R; Arkkila P
World J Gastroenterol; 2023 May; 29(17):2666-2678. PubMed ID: 37213403
[TBL] [Abstract][Full Text] [Related]
18. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
